LAWSUITS NEWS & LEGAL INFORMATION
Genotropin Growth Hormone Drug
Genotropin (somatropin) is a human growth hormone (HGH) injection that has had controversy regarding non-approved uses of the drug.
The drug has been approved for prescription to infants, children and adults of all ages for the treatment of several growth-inhibiting diseases such as Small for Gestational Age (SGA) disease, Growth Hormone Deficiency (GHD), Prader-Willi Syndrome (PWS) and even Adult Growth Hormone Deficiency (aGHD). These diseases can affect physical growth and critical organ development.
Allegations from a former executive blame Pharmacia, Genotropin's original manufacturer, for promoting off-label uses of the drug, such as an anti-aging solution. Promoting non-FDA approved uses or off-label uses of a drug is an illegal action.
Pfizer bought Pharmacia in 2003 and is working with officials to resolve these legal accusations. Genotropin is currently the world's leading growth hormone and earned approximately $736 million in 2004. In Europe and Japan, Gentropin is also approved for the treatment of Turner Syndrome and for children who suffer stunted growth from chronic kidney insufficiency.
Side effects of Genotropin can include muscle pain, change in blood sugar levels, increased thirst or urination, respiratory problems, or possible allergic reactions.
In 2003, the FDA issued a safety warning after numerous reports of death, linked to respiratory problems, in pediatric patients prescribed Genotropin for Prader-Willi Syndrome. (May-30-03) [FDA]
Published on Mar-27-06
The drug has been approved for prescription to infants, children and adults of all ages for the treatment of several growth-inhibiting diseases such as Small for Gestational Age (SGA) disease, Growth Hormone Deficiency (GHD), Prader-Willi Syndrome (PWS) and even Adult Growth Hormone Deficiency (aGHD). These diseases can affect physical growth and critical organ development.
Allegations from a former executive blame Pharmacia, Genotropin's original manufacturer, for promoting off-label uses of the drug, such as an anti-aging solution. Promoting non-FDA approved uses or off-label uses of a drug is an illegal action.
Pfizer bought Pharmacia in 2003 and is working with officials to resolve these legal accusations. Genotropin is currently the world's leading growth hormone and earned approximately $736 million in 2004. In Europe and Japan, Gentropin is also approved for the treatment of Turner Syndrome and for children who suffer stunted growth from chronic kidney insufficiency.
Side effects of Genotropin can include muscle pain, change in blood sugar levels, increased thirst or urination, respiratory problems, or possible allergic reactions.
Genotropin in the News
Ex-Pharmacia Vice-President filed a whistleblower lawsuit against Pharmacia and Pfizer for promoting Genotropin as an anti-aging treatment to doctors. Investigations continue. (Mar-20-06) [BUSINESS WEEK]In 2003, the FDA issued a safety warning after numerous reports of death, linked to respiratory problems, in pediatric patients prescribed Genotropin for Prader-Willi Syndrome. (May-30-03) [FDA]
Register your Genotropin Complaint
If you or a loved one has suffered damages related to the treatment of Genotropin in approved or non-approved uses, you may qualify for damages or remedies that may be awarded in a possible lawsuit. Please click the link below to submit your complaint to a lawyer for a free evaluation.Published on Mar-27-06
READ MORE Drugs/Medical Settlements and Legal News
READER COMMENTS
Christopher Simmons
on
KAREN Jones
on